Why Prior Authorization Matters for Pharma

10/02/23 • 30 min

It’s hard to think of an aspect of health care more vexing than prior authorizations. In fact, prior authorizations are so frustrating that Congress is looking into a legislative solution.

This episode of The IDI we have two guests to explain the state of prior authorization and how to improve the process.

John Hennessy is a principal with Valuate Health with a background in oncology and cancer care.

Syam Palakurthy is co-founder and CEO of SamaCare, a company that streamlines the prior authorization process for medical benefit drugs.

Follow Valuate on LinkedIn.

It’s hard to think of an aspect of health care more vexing than prior authorizations. In fact, prior authorizations are so frustrating that Congress is looking into a legislative solution.

This episode of The IDI we have two guests to explain the state of prior authorization and how to improve the process.

John Hennessy is a principal with Valuate Health with a background in oncology and cancer care.

Syam Palakurthy is co-founder and CEO of SamaCare, a company that streamlines the prior authorization process for medical benefit drugs.

Follow Valuate on LinkedIn.

Previous Episode

Cancer Care, Wellness and Pharma: An Unlikely Combination

Pharma and biotech have developed amazing therapies and treatments to help people living with cancer. But effective cancer care should be more than just chemo and an effective drug.

Exercise and wellness can help. A lot.

What role should pharmaceutical manufacturers and market access teams play in exercise and wellness for cancer patients though? Do they incorporate exercise? Isn’t their cancer-fighting drug enough?

Today’s guests believe pharma and market access should factor in exercise and wellness when treating cancer. And they’ll explain how pharma and market access can take all this into consideration.

John Hennessy is a principal with Valuate Health. He’s been on The IDI many times and he’s held many roles in the world of oncology and cancer care.

First-time IDI guest Sami Mansfield is the founder of Cancer Wellness for Life, an organization focused on developing oncology exercise resources for individuals, hospitals, and corporations. She’s been in this space for more than 20 years and was one of the first oncology exercise specialists in the United States.

Here are just a few research findings about the benefits of wellness and exercise on cancer care patients, including two articles co-authored by Sami Mansfield.

Follow Valuate on LinkedIn or visit us at ValuateHealth.com.

Next Episode

Fighting Breast Cancer is Not a Solitary Struggle

Getting a cancer diagnosis and navigating treatment can be a lonely experience, as guest Cora Meese shares on this episode of The IDI.

Thanks to early detection, Cora is now a breast cancer survivor, but she didn’t get there on her own.

With the help of friends and family, including podcast guest John Hennessey, Cora was able to successfully navigate her oncology journey, and connect with groups like the Young Survival Coalition.

As we recognize Breast Cancer Awareness Month, listen to Cora share her personal journey and reflect on how her insider knowledge as a cancer patient has impacted her work in market access.

Cora Meese, MBA, is Executive Vice President, Director of Client Services, for Entree Health.

John Hennessy is a principal with Valuate Health and Vice President of the Board of Directors of the Young Survival Coalition.

Follow Valuate on LinkedIn.